Leader mondial incontestable des "Proprotéines Convertases", ayant cloné sept des neuf Convertases, Nabil G. Seidah démontre leurs implications dans plusieurs pathologies humaines, notamment le rôle de PCSK9 dans l'hypercholestérolémie familiale. Il est à l'origine du médicament le plus efficace à ce jour pour réduire le LDL-cholestérol sanguin. Il est auteur de plus de 760 publications et a prononcé 470 conférences dans 30 pays. Ses découvertes majeures font partie des manuels de biochimie et de médecine. Passionné par la découverte, il a formé une relève de 150 étudiants/chercheurs. Son ...

Professor, University of Ottawa

Dr. Angel M. Foster is a Professor in the Faculty of Health Sciences, University of Ottawa. She holds a doctorate from the University of Oxford, an MD from Harvard Medical School, and master’s and bachelor’s degrees from Stanford University. A global abortion researcher, Dr. Foster leads projects in 22 countries. She has authored more than 100 articles and co-edited three books. She is the National Abortion Federation Canada’s Board Chair and Editor-in-Chief of Perspectives on Sexual and Reproductive Health. The recipient of numerous awards, she received the Guttmacher Institute’s 2017 ...

Vice Dean, McMaster University

Dina Brooks is a Canada Research Chair (Tier 2) in Rehabilitation in Chronic Obstructive Pulmonary Disease. Her research experience has included varied models (e.g., anaesthetized animals, conscious animals and humans) and different research approaches. She is presently involved in research in two main patient populations: individuals with chronic lung disease and those with cardiovascular disease.